ANTIBIOTICE IASI
78 articole · RSS
Antibiotice Iasi Plans To Register Over 25 Products In Vietnam
Antibiotice Iasi, one of the leading players in the local pharmaceuticals industry and the main producer of the active substance nystatin globally, plans to register in Vietnam over 25 produ...
Antibiotice Iasi To Start Payment Of RON6.7M Dividends As Of Sept 20
Shareholders of Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) announced the payment of dividends, in the amount of RON6.7 million, from the 2018 net profit, starting...
Antibiotice Iasi Posts Higher Sales, Profit in 1H/2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Thursday reported total sales of RON172.3 million in the first half of the year, up 9%, and a net profit of RON22.3...
Antibiotice Iasi 9-Month Sales Up 3% On Year To RON241M
Pharmaceutical company Antibiotice Iasi (ATB.RO) on Wednesday said its sales income rose 3% to RON241 million and its net profit rose 5% to RON21.17 million year-on-year in January-September...
Antibiotice Iasi To Pay Out RON17.8M Worth Of Dividends, At 5% Yield
Pharmaceutical company Antibiotice Iasi (ATB.RO), 53% held by the Health Ministry, has approved a gross dividend of RON0.0265 per share, the equivalent of a nearly 5% yield.
Antibiotice Iasi Sales Revenue Up 3%, Net Profit Up 14% In First 9 Months Of 2017
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Wednesday said it registered sales revenue of RON234 million in January-September 2017, up 3% from the year-earlier period, and its...
Antibiotice Iasi GM: Romania Has Europe's Lowest Drug Prices And World's Highest Clawback Tax
Ioan Nani, general manager of Romanian state-run drugmaker Antibiotice Iasi, on Wednesday said Romania suffers from excessive regulations which makes it hard to build on a long-term policy o...
Antibiotice Iasi 1Q Profit Down 26% To RON5.3M, Turnover Up 1% To RON55.4M
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Monday said it registered a profit of RON5.3 million in January-March 2017, down 26% on the year.
Antibiotice Iasi To Pay Dividends At A 4% Yield From 2016 Profit
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will pay dividends of RON0.023/share from 2016 profit, at a 4.1% yield, the company said in a statement to Bucharest Stock Exchange Mon...